Global Health Limited (MEDANTA) Earnings Call Transcripts

Global Health Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Global Health Limited (Medanta) reported a robust performance with total income reaching INR 11,958 million, a 25% increase year-on-year, and a profit after tax of INR 1,417 million, reflecting a 40% growth. The company highlighted strong operational momentum, particularly in patient volumes and occupancy rates, which have improved significantly across its facilities. Management maintained a positive outlook, expecting continued growth driven by ongoing expansion projects and operational efficiencies, although they cautioned about potential losses from the Noida facility in the near term.

Reported metrics

Guidance from management

Management expects the Noida facility to break even in the second half of FY '27 and anticipates continued revenue growth driven by operational improvements and expansion projects.

What management said

So we do expect this unit to break even during the course of this year, but I would say that probably we would look at second half of next year rather than to look at giving you a number on quarter. But during the course of the second half of this financial year, we do expect the unit to breakeven. Our occupancy in our Noida Hospital is currently running somewhere around 30%. And obviously, you will appreciate that b...

So we are sitting in the first half of FY '26. Just to give you -- sorry, for FY '27. Just to give you an idea, our Noida facility for construction start to construction end took approximately 3 years. And normally, hospitals of this scale take about that much time to get built out. So I think that we should assume that they will take about the same amount of time. Maybe if we are sitting in May of 2026, you would sa...

What analysts pressed on

Analysts expressed concerns regarding the ramp-up of the Noida facility and its potential for continued losses in the near term. They also inquired about the impact of new hospital openings on patient volumes and clinician retention in the competitive Gurgaon market.

Main topics on the call

• Revenue Growth — Medanta's total income grew by 25% year-on-year in Q4 FY '26, driven by strong patient volumes and improved realizations. Management stated, "Our total income for the quarter stood at INR 11,958 million, reflecting a gro...
• Noida Facility Performance — The Noida facility reported a revenue of INR 525 million in Q4 FY '26, with EBITDA losses reducing to INR 236 million from INR 320 million in Q3 FY '26. Management noted, "We do expect this unit to break even during the ...
• International Revenue Growth — International patient revenue increased by 22% year-on-year to INR 679 million, contributing positively to overall revenue growth. Management highlighted, "We see continued runway as Noida's international funnel activate...
• Operational Efficiency Improvements — The company improved its EBITDA margins to 24.3% in Q4 FY '26, with a focus on operational efficiencies and cost management. Management stated, "We are taking some further actions on the optimization of our costs," indic...

Read the full Global Health Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 4 Global Health Limited earnings call transcripts on record, spanning February 5, 2025 to July 31, 2026. Based on this history, Global Health Limited reports semi-annually. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MEDANTA

Exchange

NSEI

Country

IN

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

4

First call

February 5, 2025

Most recent

July 31, 2026

Reporting cadence

semi-annually